###begin article-title 0
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
SOX6 binds CtBP2 to repress transcription from the Fgf-3 promoter
###end article-title 0
###begin p 1
###xml 97 118 97 118 <email xmlns:xlink="http://www.w3.org/1999/xlink">dickson@icrf.icnet.uk</email>
To whom correspondence should be addressed. Tel: +44 20 7269 3336; Fax: +44 20 7269 3094; Email: dickson@icrf.icnet.uk
###end p 1
###begin p 2
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 468 475 468 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ</italic>
###xml 511 515 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 520 525 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 650 655 650 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 728 733 728 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 830 835 830 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CtBP2</italic>
###xml 1196 1201 1196 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 1327 1332 1327 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
###xml 247 252 <span type="species:ncbi:4932">yeast</span>
###xml 571 576 <span type="species:ncbi:10090">mouse</span>
###xml 753 758 <span type="species:ncbi:4932">yeast</span>
###xml 824 829 <span type="species:ncbi:10090">Mouse</span>
###xml 888 893 <span type="species:ncbi:4932">yeast</span>
Fgf-3 is expressed in a complex pattern during mouse development. Previously, an essential regulatory element PS4A was identified in the promoter region, and shown to bind at least three factors. To identify the transcription factor(s), we used a yeast one-hybrid screen and obtained a novel Sox6 cDNA (SOX6D). When introduced into cells it strongly repressed activity from both an Fgf-3 reporter gene as well as an artificial promoter containing three PS4A elements. In situ hybridisation analysis showed that Sox6 and Fgf-3 are co-expressed in the otic vesicle of E9.5 mouse embryos in a mutually exclusive pattern, consistent with a repression of Fgf-3 transcription by SOX6. To characterise additional factor(s) involved in Fgf-3 gene repression, a yeast two-hybrid screen was used with the N-terminal portion of SOX6D. Mouse CtBP2 cDNA clones were isolated and shown to bind SOX6 in yeast and mammalian cells. Furthermore, mutational analysis of SOX6 showed that binding to CtBP2, and its responsiveness to this co-repressor, were dependent on a short amino acid sequence motif PLNLSS. Co-expression studies in NIH3T3 cells showed that SOX6 and CtBP2 co-operate to repress activity from the Fgf-3 promoter through the enhancer element PS4A. These results show that SOX6 can recruit CtBP2 to repress transcription from the Fgf-3 promoter.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 132 140 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 142 149 142 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c1">1</xref>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c5">5</xref>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c6">6</xref>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c10">10</xref>
###xml 337 342 <span type="species:ncbi:10090">mouse</span>
Fibroblast growth factors (Fgfs) comprise a large family of related proteins that display a broad spectrum of biological activities in vitro. In vivo, several Fgfs have been implicated as intercellular signalling molecules in embryogenesis, homeostasis and tissue repair (reviewed in 1-5). Fgf-3 is expressed at several locations in the mouse embryo suggesting multiple roles during development. Moreover, targeted germ line disruption of Fgf-3 results in abnormalities of the inner ear and fusion of the caudal vertebrae (6-10).
###end p 4
###begin p 5
###xml 90 91 90 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 174 179 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c11">11</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c13">13</xref>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c14">14</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c15">15</xref>
###xml 492 493 492 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c16">16</xref>
 Treatment of F9 embryonal carcinoma cells with retinoic acid and dibutyryl cyclic AMP (Bt2cAMP) preferentially induces markers of parietal endoderm, including expression of Fgf-3 (11-13). Using F9 cells as a model, we previously identified an essential complex regulatory element (PS4A) within the 5' proximal region of the Fgf-3 promoter (14,15). At least three factors bind co-operatively to PS4A. One factor identified as GATA-4 mediates induction of transcription by retinoic acid and Bt2cAMP. However, other proteins necessary for co-operative binding with GATA-4 have yet to be identified (16).
###end p 5
###begin p 6
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c17">17</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c18">18</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c19">19</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c21">21</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c22">22</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c26">26</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c27">27</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c29">29</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c19">19</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c20">20</xref>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c30">30</xref>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c32">32</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c23">23</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c27">27</xref>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c33">33</xref>
###xml 825 827 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c34">34</xref>
 SOX proteins constitute a family of more than 25 transcription factors related by homology within their HMG-box DNA-binding domain to the mammalian testis determining factor SRY (17,18; reviewed in 19-21). SOX proteins may bind directly to their target promoters (22-26), or affect transcription indirectly by interacting with other components of the transcription machinery (27-29). The SOX family of transcription factors are expressed in adult tissues as well as embryonic locations where they are often implicated in cell fate decisions (19,20). For example, SOX1, 2, 3, 11 and SOXD have been implicated in neural development (30-32), and SOX1, 2, 3 and 9 in lens development (23,27,33). Recently, an unexpected interaction between SOX proteins and beta-catenin has suggested that they may also modulate Wnt signalling (34).
###end p 6
###begin p 7
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c35">35</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c36">36</xref>
###xml 338 348 338 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c37">37</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c38">38</xref>
###xml 692 694 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c39">39</xref>
###xml 695 697 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c41">41</xref>
###xml 338 348 <span type="species:ncbi:7227">Drosophila</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
 In addition to the inherent activating or repressing activities of transcription factors, promoter activity may also be modulated by the association of co-activators or co-repressors (reviewed in 35). A recently defined class of co-repressor identified by their interactions with the adenovirus E1A protein are the CtBP proteins (36). A Drosophila homologue of human CtBP1 (dCtBP) was shown to interact with the transcriptional repressors Hairy, Knirps and Snail (37,38). In addition, CtBP homologues were shown to associate and act as co-repressors with basic Kruppel-like factor, a zinc finger-homeodomain protein deltaEF1, and the vertebrate homologues of Polycomb proteins XPc and HPC2 (39-41).
###end p 7
###begin p 8
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 236 243 236 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 358 365 358 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 662 667 662 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 70 75 <span type="species:ncbi:4932">yeast</span>
###xml 383 388 <span type="species:ncbi:4932">yeast</span>
###xml 451 456 <span type="species:ncbi:10090">mouse</span>
 In this study we show that PS4A contains a SOX binding site. Using a yeast one-hybrid screen a splice variant of Sox6 (SOX6D) was isolated and shown by transfection experiments to act as a repressor of Fgf-3 transcription. Whole mount in situ hybridisation analysis on early embryos identified the otic vesicle as a potential site of Fgf-3/SOX6 interaction in vivo. In a subsequent yeast two-hybrid screen using part of the SOX6 protein, we isolated mouse CtBP2 as a co-repressor that interacts with SOX6. Point mutation analysis showed that SOX6 interacts with CtBP2 through the sequence motif PLNLSS. Moreover, reporter assays confirmed that transcription of Fgf-3 is negatively regulated through an interaction of SOX6 with CtBP2.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Electrophoretic mobility shift assay (EMSA)
###end title 10
###begin p 11
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c16">16</xref>
###xml 171 179 171 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 368 369 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c42">42</xref>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c28">28</xref>
Experimental procedures and conditions were as previously described except that the non-specific competitor was poly(dG-dC):poly(dC-dG) (Amersham Pharmacia Biotech) (16). In vitro transcribed and translated SOX6 proteins were synthesised from pCI-neo/Sox6 DNA (described below) using TnT Coupled Reticulocyte Lysate System (Promega). SOX6 protein fused to glutathione S-transferase (GST) was generated from a cDNA fragment cloned into pGEX-5X-1 (Pharmacia Biotech). Bacterial extracts expressing the fusion protein (pGEX/Sox6) were purified using a MicroSpin GST Purification Module (Pharmacia Biotech). The truncated SOX6 protein pGEX/Sox6DB was similarly prepared. It comprised 132 amino acids (523-654) of SOX6D, encompassing the 80 residues of the HMG-box. Anti-SOX6 sera were kindly provided by Dr Shinya Yamashita (Nippon Suisan Kaisha Ltd, Tokyo, Japan) (42) and Dr Veronique Lefebvre (The University of Texas, TX) (28). Both antisera gave similar results.
###end p 11
###begin title 12
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast one-hybrid and two-hybrid screening
###end title 12
###begin p 13
###xml 98 106 98 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HISi-4Ay</italic>
###xml 112 121 112 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZi-4Ay</italic>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c16">16</xref>
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 469 476 469 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL4-AD</italic>
###xml 560 561 560 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c16">16</xref>
###xml 745 749 745 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 809 817 809 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL4-DBD</italic>
###xml 895 900 895 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CtBP2</italic>
###xml 1100 1104 1100 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 1109 1114 1109 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CtBP2</italic>
###xml 1165 1173 1165 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL4-DBD</italic>
###xml 1187 1194 1187 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL4-AD</italic>
###xml 1274 1278 1274 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 598 603 <span type="species:ncbi:4932">Yeast</span>
###xml 1087 1092 <span type="species:ncbi:4932">yeast</span>
Yeast one-hybrid screening was carried out according to MATCHMAKER One-Hybrid System (Clontech). pHISi-4Ay and pLacZi-4Ay bait plasmids were constructed by inserting a synthetic DNA oligomer corresponding to the central element of the PS4A enhancer contained in the Fgf-3 promoter (16). cDNAs were synthesised from poly(A)+ RNA prepared from differentiated F9 cells using TimeSaver cDNA Synthesis Kit (Pharmacia Biotech), and used as a dF9 cDNA library after fusion to GAL4-AD sequence in pGAD424. Procedures for isolation of total RNA and selection of poly(A)+ RNA were described previously (16). Yeast two-hybrid screening was carried out according to the MATCHMAKER Two-Hybrid System (Clontech). The bait plasmid was constructed by fusion of Sox6 cDNA corresponding to 523 amino acids at the N-terminus to GAL4-DBD sequence in pGBT9. After screening the dF9 cDNA library described above, the CtBP2 cDNA clone obtained was found to lack 30 nt from the 5' initiation codon. The cDNA was extended beyond the initiation codon by 5' RACE System (Gibco BRL). For two-hybrid interactions in yeast cells, Sox6 and CtBP2 cDNAs encoding full-length proteins were fused to GAL4-DBD in pGBT9 and GAL4-AD in pGAD424, respectively. Point or deletion mutations were introduced into the Sox6 insert using QuickChange Site-Directed Mutagenesis Kit (Stratagene).
###end p 13
###begin title 14
Transfection assay
###end title 14
###begin p 15
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c16">16</xref>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 255 260 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CtBP2</italic>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c14">14</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c16">16</xref>
The luciferase reporter plasmids ptkLuc, p(4Ax3)tkLuc and pFgf-3/Luc used in transfection experiments have been described previously (16). Expression plasmids, pCI-neo/Sox6 and pCI-neo/CtBP2 were constructed by inserting the coding region of the Sox6 and CtBP2 cDNAs, respectively, into the multiple-cloning site of pCI-neo (Promega). Procedures for cell culture, transfection with plasmid DNA by the calcium phosphate-DNA precipitation method, preparation of cell extracts and luciferase assays have been described previously (14-16).
###end p 15
###begin title 16
Immunoprecipitation and immunoblotting
###end title 16
###begin p 17
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 391 394 391 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apa</italic>
###xml 396 399 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 621 626 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CtBP2</italic>
###xml 845 846 845 846 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 849 850 849 850 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 862 863 862 863 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 865 866 865 866 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 880 881 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
The plasmid for expression of SOX6 tagged with six histidine residues at the C-terminus, pCI-neo/Sox6HT was constructed by insertion of the Sox6 coding region into pET-21b(+) (Novagen) and then re-insertion of the coding region with the tag into pCI-neo. The mutations introduced for the two-hybrid interaction experiments described above were transferred to pCI-neo/Sox6HT by replacing the ApaI-EcoNI fragment of the wild-type cDNA with the equivalent fragment for each of the mutated plasmids. The plasmid for expression of CtBP2 tagged with FLAG at the N-terminus, pCMV/FLAG-CtBP2, was constructed by insertion of the CtBP2 coding region into pCMV-Tag 2 (Stratagene). The plasmid DNAs were introduced into Cos7 cells by an electroporation method. Briefly, cells were trypsinised and resuspended in K-PBS (30.8 mM NaCl, 120.7 mM KCl, 8.1 mM Na2HPO4, 1.46 mM KH2PO4 and 5 mM MgCl2). After adding 20 microg DNA for each 10 cm dish of cultured cells the suspension was electrically pulsed at 250 V, 960 microF using Bio-Rad Gene Pulser and cultured for a further 2 days. Cells were lysed in a lysis buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 10 microg/ml leupeptin, 1 mM PMSF, 1.0% Triton X-100). His-tagged SOX6 and FLAG-tagged CtBP2 proteins in the cell lysates were immunoprecipitated with Protein G-Sepharose (Pharmacia Biotech) coated with anti-His serum (Santa Cruz) and anti-FLAG serum (Eastman Kodak Company), respectively. The immunoprecipitates were separated by SDS-PAGE and analysed by immunoblotting.
###end p 17
###begin title 18
Northern blot hybridisation
###end title 18
###begin p 19
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c16">16</xref>
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Acc</italic>
###xml 168 172 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 185 188 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 220 225 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CtBP2</italic>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hEF1a</italic>
###xml 368 371 368 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
Procedures for isolation of total RNA, selection of poly(A)+ RNA and northern blot hybridisation were described previously (16). An AccI fragment (1.3 kb, 363-1711) of Sox6 cDNA and an EcoRI fragment (1.1 kb, 1-1079) of CtBP2 cDNA were used for hybridisation as probes. The hEF1a cDNA clone was obtained from Dr Sakamaki (Kyoto University, Kyoto, Japan), and a 2.3 kb BamHI fragment was used for hybridisation.
###end p 19
###begin title 20
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ</italic>
In situ hybridisation
###end title 20
###begin p 21
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c43">43</xref>
###xml 113 116 113 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 119 122 119 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 183 186 183 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sma</italic>
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Whole mount in situ hybridisation of mouse embryos was done according to a method described previously (43). The BamHI-EcoRI fragment (0.6 kb) in the third exon of Fgf-3 and the XbaI-SmaI fragment (0.26 kb) of Sox6 were cloned into LITMUS 28 (New England Biolabs). RNA probes were synthesised from the linearised plasmid DNAs with T7 RNA polymerase (Boehringer Mannheim) using digoxigenin-11-UTP (Boehringer Mannheim). Hybridised probe was detected using BM Purple AP substrate (Boehringer Mannheim) after treatment with Anti-Digoxigenin-AP, Fab fragment (Boehringer Mannheim).
###end p 21
###begin title 22
RESULTS
###end title 22
###begin title 23
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
Identification of SOX6 as a binding protein to PS4A of the Fgf-3 promoter
###end title 23
###begin p 24
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 302 303 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 378 382 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ</italic>
###xml 460 464 460 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 87 92 <span type="species:ncbi:4932">yeast</span>
To identify regulatory factors that bind to the central region of the PS4A enhancer, a yeast one-hybrid screen was used with a bait containing just the central binding site from PS4A, with a cDNA library prepared from F9 cells. Sixteen primary colonies were isolated from 1.5 x 107 transformants on His- plates, and two of these were also positive in a secondary screen using a LacZ reporter (see Materials and Methods). Sequencing revealed an insert encoding Sox6 cDNA.
###end p 24
###begin p 25
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f1">1</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c44">44</xref>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f1">1</xref>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6D</italic>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f1">1</xref>
###xml 472 477 472 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6A</italic>
###xml 491 500 491 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6B/C/D</italic>
###xml 630 635 630 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6D</italic>
###xml 672 681 672 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6A/B/C</italic>
###xml 731 736 731 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6D</italic>
###xml 741 746 741 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6A</italic>
 A schematic representation of the previously described SOX6 isoforms and the variant that we have designated SOX6D is shown in Figure 1A (44). SOX6D most closely resembles SOX6C, but has 20 amino acids missing (S3) between the second potential coiled-coil domain and the HMG-box (Fig. 1B). RT-PCR was used to establish the presence of Sox6D mRNA in F9 cells. Primers flanking the variable S2 region (Fig. 1A) produced two products corresponding to the size predicted for Sox6A (578 bp) and Sox6B/C/D (455 bp), respectively. Similarly, primers flanking the variable S3 region produced two products, a signature band of 159 bp for Sox6D and another of 219 bp indicative of Sox6A/B/C (data not shown). Hence, signature fragments for Sox6D and Sox6A were detected, confirming their expression in F9 cells. However, at present there is no evidence to suggest specific functional differences amongst the SOX6 isoforms.
###end p 25
###begin title 26
Binding of SOX6 proteins to the central element of PS4A
###end title 26
###begin p 27
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f2">2</xref>
###xml 212 213 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f2">2</xref>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f2">2</xref>
###xml 453 458 453 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c16">16</xref>
###xml 652 653 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f2">2</xref>
###xml 777 778 777 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f2">2</xref>
###xml 879 880 879 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f2">2</xref>
###xml 840 846 <span type="species:ncbi:9986">rabbit</span>
To confirm SOX6 binding to PS4A, we initially used in vitro transcribed and translated SOX6 protein in an EMSA (Fig. 2A). Several complexes with different mobilities were found associated with a PS4A probe (Fig. 2A, lane 1). The complexes were absent (Fig. 2A, lane 2) when a mutated probe (4AyM4) was used. This mutated probe has two base substitutions and was previously shown to abolish factor binding to PS4A, as well as to cause a complete loss of Fgf-3 promoter activity in cell transfection assays (16). Inclusion of SOX6 antiserum in the EMSA shifted the SOX6 specific bands to the top of the gel confirming its presence in the complexes (Fig. 2A, lane 3). These results demonstrate the binding of SOX6 protein to the central element of PS4A. A non-specific band (Fig. 2, asterisk) in the EMSA was identified by its appearance with rabbit reticulocyte lysate alone (Fig. 2B, lane 2).
###end p 27
###begin p 28
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f2">2</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c16">16</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c28">28</xref>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c42">42</xref>
###xml 1084 1085 1084 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f2">2</xref>
###xml 1291 1292 1291 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f2">2</xref>
###xml 1553 1555 1553 1555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c20">20</xref>
###xml 90 96 <span type="species:ncbi:9986">rabbit</span>
 Full-length recombinant SOX6 protein binds PS4A poorly in an EMSA, unless accompanied by rabbit reticulocyte lysate (Fig. 2), indicating that efficient SOX6 binding is co-operative and requires other factors. This finding is consistent with our previous point mutation analysis showing co-operative binding to PS4A (16). Moreover, others have shown that the coiled-coil domains of full-length SOX6 permit the formation of homo- or heterodimers with other SOX proteins. These bind to pairs of HMG-box motifs, and can interfere with SOX protein binding to a single HMG-box motif, as found in PS4A (28,42). In confirmation of previous observations, recombinant full-length SOX6 was found to bind strongly to a HMG-box dimer motif (data not shown). Specificity of SOX6 binding was further demonstrated by using a truncated recombinant SOX6 protein (GST-SOX6DB) that lacks the coiled-coil domain implicated in dimer formation. Purified GST-SOX6DB was used in EMSA with a series of oligonucleotide probes, each containing a single base substitution across the central region of PS4A (Fig. 2C). Mutations 4AM15, 4AyM6, 4AyM7 and 4AM16 severely diminished binding while 4AM14 and 4AyM5 significantly reduced it, from which (CT)ATTGT could be deduced as the core recognition sequence for SOX6 (Fig. 2D). This is similar to the previously determined recognition sequence for the central site in PS4A. The complementary strand of the identified core binding sequence is close to the consensus sequence (A/T)(A/T)CAA(A/T)G reported for several other SOX proteins (20).
###end p 28
###begin title 29
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
Repression of the Fgf-3 promoter activity by SOX6
###end title 29
###begin p 30
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 184 185 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f3">3</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f3">3</xref>
###xml 359 361 359 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tk</italic>
###xml 425 430 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c14">14</xref>
###xml 771 776 771 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 991 996 991 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 1194 1196 1194 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c35">35</xref>
###xml 1248 1253 1248 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
To determine whether SOX6 expression could affect transcription from the Fgf-3 promoter, differentiated F9 cells were co-transfected with one of two luciferase reporter plasmids (Fig. 3A), together in the presence or absence of a SOX6 expression plasmid (Fig. 3B). The reporter constructs contained either three copies of the PS4A enhancer fused to a minimal tk promoter [p(4Ax3)tkLuc], or a 1.7 kb fragment encompassing the Fgf-3 proximal promoter region (pFgf-3/Luc) (14). Co-transfection of a SOX6 expression plasmid had little effect on transcription from the control vector ptkLuc. However, transcription from the reporters p(4Ax3)tkLuc and pFgf-3/Luc was substantially reduced when co-expressed with SOX6, showing that SOX6 is able to repress transcription from an Fgf-3 promoter. Similar results were also obtained in co-transfection experiments using undifferentiated F9, NIH3T3 and Cos7 cells, although the effect was less marked since these cell lines only express weakly from the Fgf-3 reporter (data not shown). Although SOX6 is known to be an enhancer of transcription, these observations suggest that it can also function in gene repression, perhaps by recruiting a co-repressor (35). As the SOX binding site in PS4A is essential for Fgf-3 promoter activity, it is not possible using base mutations of the site to demonstrate a relief of the repression by SOX6.
###end p 30
###begin p 31
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox2</italic>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox7</italic>
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox13</italic>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox17</italic>
###xml 350 357 350 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 390 394 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
 Analysis of F9 cells using degenerate RT-PCR showed the presence of Sox6, but also several other Sox transcripts (Sox2, Sox7, Sox13, Sox17) consistent with the pluripotential nature of F9 cells, and the role of SOX proteins in lineage determination (data not shown). Therefore, to provide evidence for a potential interaction between these proteins in vivo, we examined sites of Fgf-3 and Sox6 expression.
###end p 31
###begin title 32
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox-6</italic>
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
Co-expression of Sox-6 and Fgf-3 in the embryonic inner ear
###end title 32
###begin p 33
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c7">7</xref>
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c9">9</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c45">45</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c46">46</xref>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f4">4</xref>
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f4">4</xref>
###xml 667 671 667 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 689 690 689 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f4">4</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c46">46</xref>
###xml 727 732 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 745 749 745 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 825 829 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 834 839 834 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 944 949 944 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
Previous studies have reported that Fgf-3 and Sox6 are both expressed in the otic vesicle during early ear development (7,9,45,46). Using embryos from embryonic day 9.5 (E9.5), we confirmed the otic vesicle as a site of expression for both these genes (Fig. 4). To determine which cells were expressing Fgf-3 and Sox6 RNA, the stained embryos were sectioned for histological examination. Fgf-3 RNA was found to be localised to the presumptive sensory epithelia, which forms the inner ear, as well as to the delaminating neuronal precursors that migrate to form the cochleovestibular ganglion (Fig. 4A and B). The otic vesicle at E9.5 was the only site of discernible Sox6 expression (Fig. 4D) (46). In contrast to the sites of Fgf-3 expression, Sox6 was associated with the inner epithelial layer of the otic vesicle. Hence, Sox6 and Fgf-3 were expressed in a mutually exclusive pattern, consistent with the idea that SOX6 could act to repress Fgf-3 transcription within a sub-region of the otic vesicle epithelium.
###end p 33
###begin title 34
Identification of CtBP2 as a SOX6-binding protein
###end title 34
###begin p 35
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c28">28</xref>
###xml 641 642 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c39">39</xref>
###xml 239 244 <span type="species:ncbi:4932">yeast</span>
###xml 691 696 <span type="species:ncbi:10090">mouse</span>
Previously, SOX6 was shown to act as an activator, rather than a repressor of transcription, suggesting that its regulatory activity may be dependent on its interaction with either a co-activator or co-repressor (28). Therefore, we used a yeast two-hybrid screen to search for co-repressor proteins that could bind SOX6. As bait, a polypeptide of 523 amino acids from the N-terminal part of SOX6D was fused to a GAL4 DNA binding domain that served to replace the HMG-box DNA binding region. This vector was used to screen the same differentiated F9 cDNA-GAL library described above. Two positive clones were obtained after screening 4.3 x 106 transformants. Both clones were found to encode mouse CtBP2, a recently described co-repressor protein (39). The two clones were slightly shorter than the published sequence, and were extended using 5' RACE to obtain a full-length coding sequence.
###end p 35
###begin p 36
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c37">37</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c41">41</xref>
###xml 340 341 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f5">5</xref>
###xml 452 453 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 310 315 <span type="species:ncbi:4932">yeast</span>
###xml 754 759 <span type="species:ncbi:4932">yeast</span>
 The amino acid sequence PLDLSL has been identified in some transcription factors to be a consensus motif for binding CtBP2 (37-41). A similar sequence, PLNLSS, is present in SOX6D (amino acids 383-388). Therefore, mutations were introduced into this motif to assess their effect on SOX6 binding to CtBP2 in a yeast two-hybrid system (Fig. 5). Deletion of the complete motif PLNLSS abolished the interaction. This was shown by the lack of growth on His- plates and the absence of beta-galactosidase induction. Substitution of proline by alanine (P383A) had little effect, whereas substitution of the leucine by histidine (L386H) abolished the interaction. These results indicate that the PLNLSS sequence in SOX6 is required for interaction with CtBP2 in yeast cells.
###end p 36
###begin p 37
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f6">6</xref>
###xml 415 416 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f6">6</xref>
###xml 571 572 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f6">6</xref>
###xml 807 808 807 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f6">6</xref>
###xml 945 946 945 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f6">6</xref>
 To confirm that the binding between SOX6 and CtBP2 also occurs in mammalian cells, these proteins were co-expressed in Cos7 cells. Protein extracts derived from these cells were subjected to immunoprecipitation followed by immunoblotting (Fig. 6).   FLAG-tagged CtBP2 proteins were immunoprecipitated with an anti-FLAG serum and then the His-tagged SOX6 was revealed by immunoblotting with an anti-HIS serum (Fig. 6A, lane 1). Reciprocally, SOX6 proteins were immunoprecipitated with an anti-HIS serum and CtBP2 revealed by immunoblotting with the anti-FLAG serum (Fig. 6B, lane 1). These experiments demonstrate that SOX6 and CtBP2 can form a complex in Cos7 cells. As anticipated, neither the SOX6 PLNLSS-deletion mutant nor SOX6 with the L386H substitution formed significant complexes with CtBP2 (Fig. 6A and B, lanes 2 and 4, respectively). Moreover, in this analysis the P383A mutant also failed to form a stable complex with CtBP2 (Fig. 6A and B, lanes 3). These combined results demonstrate that in mammalian cells, the PLNLSS sequence is necessary for complex formation between SOX6 and CtBP2.
###end p 37
###begin title 38
Repression by SOX6 by recruitment of CtBP2
###end title 38
###begin p 39
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f3">3</xref>
###xml 289 294 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f7">7</xref>
###xml 418 423 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CtBP2</italic>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 505 506 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f7">7</xref>
###xml 705 710 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 823 824 823 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f7">7</xref>
As SOX6 is able to repress transcription from the native Fgf-3 promoter or an artificial promoter containing three PS4A elements (Fig. 3), we examined the effect of co-expressing CtBP2 on SOX6 activity. In differentiated F9 cells, the introduction of CtBP2 had little additional effect on Fgf-3 promoter activity above that of SOX6 alone (Fig. 7A). However, subsequent northern blot analysis indicated that endogenous CtBP2 is already expressed at very high levels compared with Sox6 in these cells (Fig. 7B). Hence, the normal level of CtBP2 is most likely in excess of that required for maximal repression by SOX6. Functional evidence for the interaction between SOX6 and CtPB2 in the repression of the Fgf-3 promoter was evident from the behaviour of the Sox6del mutant lacking the PLNLSS motif in reporter assays (Fig. 7C). The mutated SOX6 protein that was unable to bind CtBP2 was also unable to repress transcription. An EMSA using Sox6del showed that the loss of repression was not due to loss of binding activity for PS4A (data not shown).
###end p 39
###begin p 40
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CtBP2</italic>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke470f8">8</xref>
###xml 491 496 491 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
 The high endogenous level of CtBP2 in F9 cells makes them unsuitable to demonstrate a co-operative effect between co-expressed Sox6 and CtBP2. Therefore we used NIH3T3 cells which were found to express very low levels of endogenous CtBP2. In this cell line the co-operative effect of co-expressing SOX6 and CtBP2 could be clearly demonstrated (Fig. 8). Thus the reporter assays using both dF9 and NIH3T3 cells clearly demonstrate that SOX6 must recruit CtBP2 to repress the activity of the Fgf-3 promoter through the PS4A enhancer.
###end p 40
###begin title 41
DISCUSSION
###end title 41
###begin p 42
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c16">16</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c20">20</xref>
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 796 801 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 816 823 816 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 833 840 833 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 963 967 963 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 1031 1036 1031 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 1075 1079 1075 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 1084 1089 1084 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 1181 1186 1181 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 1338 1340 1338 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c47">47</xref>
###xml 1459 1464 1459 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 1659 1663 1659 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 1771 1776 1771 1776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 1827 1829 1827 1829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c10">10</xref>
###xml 1914 1918 1914 1918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 505 510 <span type="species:ncbi:4932">yeast</span>
###xml 873 878 <span type="species:ncbi:10090">mouse</span>
###xml 1285 1290 <span type="species:ncbi:10090">mouse</span>
###xml 1669 1673 <span type="species:ncbi:10090">mice</span>
###xml 1752 1756 <span type="species:ncbi:10090">mice</span>
###xml 1895 1899 <span type="species:ncbi:10090">mice</span>
In a previous study we identified PS4A as an essential regulatory element proximally located in the Fgf-3 promoter (16). Here we show that SOX6 can bind to the central region of this essential regulatory element at the sequence motif ACAAT, a site that is similar to the published consensus for other SOX protein binding sites (20). Binding of SOX6 to the Fgf-3 promoter, or a minimal artificial promoter containing three PS4A regulatory elements, results in a strong repression of transcription. Using a yeast one-hybrid screen, SOX6 was identified as an expressed protein in F9 cells. However, subsequent screening of F9 cells using RT-PCR revealed several other SOX proteins which should also bind to the SOX consensus site. Therefore, to obtain evidence that SOX6 might act as a repressor of Fgf-3 transcription in vivo, we used in situ hybridisation analysis on early mouse embryos to look for their sites of expression. The otic vesicle was the one site of Sox6 expression found in E9.5 embryos, and this was also a site for Fgf-3 expression. The expression pattern of Sox6 and Fgf-3 is complementary and mutually exclusive, consistent with SOX6 acting as a repressor of the Fgf-3 promoter. Interestingly SOX13, another group D SOX protein, is also expressed in the inner ear of mouse embryos at E13.5 but was not detected at E9.5 (47; A.Murakami, unpublished results). The SOX13 sequence also encodes potential CtBP2 binding sites and will repress the Fgf-3 promoter if over-expressed in F9 cells (A.Murakami, unpublished results). Hence it is possible that SOX13 may play a role in regulating Fgf-3 expression, but at a later stage of development. If Sox6 null mice become available then this proposal might be readily tested. In this context, mice deficient for Fgf-3 have been found to have an inner ear abnormality (10), suggesting that likewise, a similar abnormality might occur in mice deficient for Sox6.
###end p 42
###begin p 43
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Col2a1</italic>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c28">28</xref>
###xml 289 295 289 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Col2a1</italic>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c28">28</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c19">19</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c28">28</xref>
###xml 719 725 719 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Col2a1</italic>
###xml 763 768 763 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c16">16</xref>
 The collagen type II promoter (Col2a1) which is expressed in chondrocytes, is a recently identified target gene for SOX6 (28). But in this context, SOX6 functions as an activator of transcription rather than a repressor. It was shown to co-operate with SOX5 and SOX9 in the activation of Col2a1 through binding at four HMG-like sites in the minimal enhancer region (28). Based on the sequence of the HMG-box DNA-binding domain, SOX genes have been divided into several groups. For example SOX5, SOX6 and SOX13 belong to group D while SOX9 belongs to group E (19). Hetero- and homodimerizaton between group D SOX proteins appears to be mediated by the coiled-coil domain located at their N-termini (28). In contrast to Col2a1 that can accommodate SOX dimers, the Fgf-3 promoter contains only a single consensus HMG site corresponding to the central PS4A element. From this, and an earlier study, this site shows co-operative protein binding (16). This must therefore involve SOX6 and a non-SOX protein.
###end p 43
###begin p 44
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c22">22</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c26">26</xref>
###xml 241 244 241 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OPN</italic>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c48">48</xref>
###xml 319 331 315 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1-crystallin</italic>
###xml 413 415 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c49">49</xref>
 Although the SOX protein family has been principally associated with the activation of transcription (22-26), there are now examples of their being involved in the repression of transcription. For instance, Oct-4 mediated activation of the OPN gene can be repressed by SOX2 (48). In contrast to OPN promoter, the delta1-crystallin promoter is activated by SOX2 as well as SOX1, and repressed by SOX14 and SOX21 (49). Thus, depending on the promoter context, SOX2, like SOX6, can act as both a repressor and activator of transcription.
###end p 44
###begin p 45
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c4">4</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c41">41</xref>
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c36">36</xref>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c50">50</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c39">39</xref>
###xml 1010 1012 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c41">41</xref>
###xml 151 156 <span type="species:ncbi:10090">mouse</span>
###xml 554 559 <span type="species:ncbi:9606">human</span>
###xml 712 717 <span type="species:ncbi:10090">mouse</span>
 To explain the repression of Fgf-3 transcription by SOX6, we sought other proteins that could interact with this transcription factor, and identified mouse CtBP2. Binding was shown to require the amino acid motif PLNLSS which is similar to CtBP2 binding regions identified in other transcription factors (4,41). Furthermore, co-expression studies showed that CtBP2 co-operates with SOX6 to repress transcription of Fgf-3, and this repression was dependent upon the integrity of the PLNLSS motif in SOX6. CtBP was first identified as a cellular protein (human CtBP) that bound the C-terminal region of the adenovirus E1A protein (36) and attenuated its ability to activate transcription (50). More recently, two mouse homologues, CtBP1 and CtBP2, were found to associate with, and repress transcriptional activation through the basic Kruppel-like factor (39). Both CtBP1 and CtBP2 enhance transcriptional repression by deltaEF1 and are widely expressed in developing embryos with different tissue preferences (41).
###end p 45
###begin p 46
###xml 270 282 266 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1-crystallin</italic>
###xml 466 471 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
 Thus, depending on the context, SOX6 can act as an activator and repressor of transcription. This suggests a general mechanism where SOX family members recruit either co-activators or co-repressors to modulate transcription. Furthermore, a given promoter, such as delta1-crystallin may be transcriptionally activated by one set of SOX proteins and yet repressed by other members of the same protein family. We have evidence that a similar situation pertains to the Fgf-3 promoter. Preliminary data suggests that in F9 cells, SOX7 mediates activation of Fgf-3 transcription (A.Murakami, unpublished results), while from this study, in the otic vesicle SOX6 is a good candidate for its repression.
###end p 46
###begin title 47
Figures and Tables
###end title 47
###begin p 48
###xml 40 41 40 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c28">28</xref>
###xml 337 338 337 338 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
 Sequence comparison of SOX6 proteins. (A) Schematic comparison of SOX6 isoforms, SOX6A, SOX6B and SOX6C (28) together with the variant SOX6D. S1, S2 and S3 designate segments that differ between the isoforms. Two putative coiled-coil domains (1st cc and 2nd cc) and the HMG-box DNA binding domain common to all isoforms are indicated. (B) Comparison of the central region of SOX6A and SOX6D showing the divergent amino acid sequences. Identical residues are shaded.
###end p 48
###begin p 49
###xml 61 62 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in </italic>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vitro</italic>
###xml 129 131 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 266 267 266 267 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 417 419 417 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 692 693 692 693 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 822 823 822 823 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 836 838 836 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 334 340 <span type="species:ncbi:9986">rabbit</span>
###xml 374 380 <span type="species:ncbi:9986">Rabbit</span>
 Binding and recognition sequence of SOX6 proteins in PS4A. (A) EMSA using in vitro transcribed and translated SOX6 proteins and 32P-labeled probes. Lanes 1 and 3, 4A; lane 2, mutated probe 4AyM4. The + indicates addition of SOX6 antiserum after complex formation. (B) EMSA using recombinant SOX6 protein alone (lane 1) or mixed with rabbit reticulocyte lysate (lanes 3-5). Rabbit reticulocyte lysate alone (lane 2). 32P-radiolabelled probes are indicated above the lanes. Positions of complexes and a non-specific band are indicated by arrowheads and an asterisk, respectively. The two smaller complexes [lane 1 in (A)] probably arise from initiation of translation at internal AUG codons. (C) Schematic depiction showing the sequences of wild-type and point mutated PS4A probes used to establish the SOX6 binding site. (D) EMSA using 32P-labelled PS4A probes shown in (C), mixed with purified GST-Sox6DB protein.
###end p 49
###begin p 50
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 110 111 110 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke470c16">16</xref>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 240 241 240 241 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 472 475 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
 Effects of SOX6 expression on the Fgf-3 proximal promoter and an artificial promoter containing PS4A sites. (A) Schematic representation of the control and two reporter plasmids (16) used to test the effect of SOX6 on the Fgf-3 promoter. (B) Differentiated F9 cells co-transfected with a reporter plasmid (3 microg) as indicated, and either control vector (6 microg) pCI-neo or SOX6 expression vector (6 microg) pCI-neo/Sox6. A beta-galactosidase reporter (1 microg) pRL-CMV DNA was used as an internal control to normalize transfection efficiency.
###end p 50
###begin p 51
###xml 13 20 13 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 154 155 154 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 160 161 160 161 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> Sox6</italic>
###xml 182 183 182 183 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 188 189 188 189 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
###xml 88 93 <span type="species:ncbi:10090">Mouse</span>
 Whole mount in situ hybdridisation showing Fgf-3 and Sox6 expression in mouse embryos. Mouse embryos (E9.5) were hybridised with either antisense Fgf-3 (A and B) or antisense Sox6 (C and D) probes labelled with digoxigenin and detected with anti-digoxigenin alkaline phosphatase conjugated antiserum as described in Materials and Methods. The major common expression site is in the otic vesicle (OV). Sections through the otic vesticles seen in (A) and (D) are shown in (B) and (C), respectively, and demonstrate the cellular location of the labelled cells.
###end p 51
###begin p 52
###xml 88 89 88 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 192 193 192 193 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 379 380 379 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 35 40 <span type="species:ncbi:4932">yeast</span>
###xml 200 205 <span type="species:ncbi:4932">yeast</span>
 Interaction of SOX6 with CtBP2 in yeast depends on the PLNLSS sequence motif in SOX6. (A) Amino acid sequences of the putative recognition site for CtBP2 in wild-type SOX6 and mutated SOX6. (B) HF7c yeast cells were co-transformed with plasmids expressing wild-type or a mutant GAL4DBD-Sox6 and GAL4AD-CtBP2. For each transformation single colonies were tested for growth on His- plates (left) and for beta-galactosidase activity (right), respectively.
###end p 52
###begin p 53
###xml 317 318 317 318 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 472 473 472 473 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
 Interaction of SOX6 with CtBP2 in Cos7 cells depends on the PLNLSS sequence in SOX6. Histidine-tagged SOX6 and FLAG-tagged CtBP2 were co-expressed in Cos7 cells. Lanes 1 and 5, SOX6 wild-type; lanes 2 and 6, SOX6del; lanes 3 and 7, SOX6P383A; lanes 4 and 8, SOX6L386H (see Fig. 5 for mutated amino acid sequences). (A) Total cell lysates (lanes 5-8) or cell lysates immunoprecipitated with anti-FLAG serum (lanes 1-4) were analysed by immunoblotting with ant-His serum. (B) As described in (A) except cell lysates were immunoprecipitated with anti-His serum and immunoblotted with anti-FLAG serum.
###end p 53
###begin p 54
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
###xml 110 111 110 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 366 367 366 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 394 398 394 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 403 408 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CtBP2</italic>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 557 559 553 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 570 574 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 576 581 572 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CtBP2</italic>
###xml 708 709 700 701 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 787 792 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf-3</italic>
 Effect of over-expressing CtBP2 on the repression of the Fgf-3 promoter by SOX6 in differentiated F9 cells. (A) Differentiated F9 cells were co-transfected with the p(4Ax3)tkLuc reporter together with effector plasmids for the expression of SOX6, CtBP2 or SOX6 and CtBP2. Relative luciferase activities were normalised to the value obtained with the vector alone. (B) Endogenous expression of Sox6 and CtBP2 mRNAs in F9 cells. Poly(A)+ RNA (1 microg) from undifferentiated F9 (uF9) and differentiated F9 (dF9) cells was analysed by northern blotting using 32P-labelled Sox6, CtBP2 and EF1alpha as a control for RNA loading. Positions of 28S and 18S ribosomal RNAs are indicated to the right of each panel. (C) SOX6 deletion mutant lacking PLNLSS does not repress transcription from the Fgf-3 promoter. Differentiated F9 cells were co-transfected with one of the reporter plasmids and an effector plasmid for expression of SOX6 or SOX6del. Relative luciferase activities are shown. Amounts of DNAs for transfection are the same as those in Figure 3.
###end p 54
###begin p 55
 Effects of CtBP2 on the repression by SOX6 in NIH3T3 cells. NIH3T3 cells were co-transfected with each of the reporter plasmids together with expression plasmids for the expression of SOX6 and/or CtBP2 as indicated. Relative luciferase activities are normalized to the vector alone. Amounts of DNAs for transfection are the same as those used in Figure 3.
###end p 55
###begin title 56
ACKNOWLEDGEMENTS
###end title 56
###begin p 57
###xml 224 229 <span type="species:ncbi:9606">Human</span>
We thank Drs Veronique Lefebvre and Shinya Yamashita for generously providing antiserum against SOX6, and Drs Malcolm Parker and Vera Fantl for critical reading of the manuscript. This work was supported by a grant from the Human Frontier Science Program to A.M. and C.D.
###end p 57

